POLQ identifies a better response subset to immunotherapy in muscle-invasive bladder cancer with high PD-L1. Liu G, Jin K, Liu Z, Su X, et al. Cancer Med 2024;13:e6962.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu G, Jin K, Liu Z, Su X, et al. POLQ identifies a better response subset to immunotherapy in muscle-invasive bladder cancer with high PD-L1. Cancer Med 2024;13:e6962.
PMID: 38457207